Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial.
Supady A, Weber E, Rieder M, Lother A, Niklaus T, Zahn T, Frech F, Müller S, Kuhl M, Benk C, Maier S, Trummer G, Flügler A, Krüger K, Sekandarzad A, Stachon P, Zotzmann V, Bode C, Biever PM, Staudacher D, Wengenmayer T, Graf E, Duerschmied D. Supady A, et al. Lancet Respir Med. 2021 Jul;9(7):755-762. doi: 10.1016/S2213-2600(21)00177-6. Epub 2021 May 14. Lancet Respir Med. 2021. PMID: 34000236 Free PMC article. Clinical Trial.
Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support.
Lother A, Benk C, Staudacher DL, Supady A, Bode C, Wengenmayer T, Duerschmied D. Lother A, et al. Among authors: supady a. Front Cardiovasc Med. 2019 Jun 4;6:71. doi: 10.3389/fcvm.2019.00071. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31275944 Free PMC article.
First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.
Bemtgen X, Krüger K, Supady A, Duerschmied D, Schibilsky D, Bamberg F, Bode C, Wengenmayer T, Staudacher DL. Bemtgen X, et al. Among authors: supady a. ASAIO J. 2020 Jun;66(6):607-609. doi: 10.1097/MAT.0000000000001178. ASAIO J. 2020. PMID: 32472827 Free PMC article.
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J, Kern WV, Duerschmied D, Supady A, Bode C, Staudacher DL, Wengenmayer T. Rilinger J, et al. Among authors: supady a. Trials. 2020 Jun 3;21(1):470. doi: 10.1186/s13063-020-04447-3. Trials. 2020. PMID: 32493514 Free PMC article.
Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19.
Rieder M, Goller I, Jeserich M, Baldus N, Pollmeier L, Wirth L, Supady A, Bode C, Busch HJ, Schmid B, Duerschmied D, Gauchel N, Lother A. Rieder M, et al. Among authors: supady a. J Thromb Thrombolysis. 2020 Oct;50(3):558-566. doi: 10.1007/s11239-020-02202-8. J Thromb Thrombolysis. 2020. PMID: 32617807 Free PMC article.
85 results